Anticoagulants, atherosclerosis and hyperlipidaemia drugs Flashcards
Heparin:
inhibits the actions of thrombin, factor X and factor IX, which are needed in the clotting cascade. Therefore, fibrinogen cannot be converted to fibrin and a clot cannot form. Also increases the strength of binding of ATIII (thrombin inhibitor) to thrombin and Factor Xa. Molecule carries a high negative charge. Given by injection. Risk of haemorrhage.
Warfarin:
related in structure to Vitamin K. Acts by competitively inhibiting an enzyme involved in the recycling of Vitamin K (vitamin K reductase), which is needed for the formation of various clotting factors.
Aspirin:
antiplatelet drug. Irreversibly inhibits platelet COX enzyme, reducing TxA2 synthesis. TxA2 is a major stimulant for platelet aggregation. Platelets have no nuclei so cannot synthesise new enzyme so aggregation is reduced until new platelets are made (7-10 days).
Statins:
competitively inhibit HMG-CoA reductase (rate limiting enzyme in production of cholesterol), thereby lowering the liver’s production of cholesterol. Lowered cholesterol leads to more LDL receptors and so, increased removal of LDL (bad cholesterol) from plasma.
Ezetimibe:
inhibits a specific cholesterol transporter in gut, inhibiting intestinal cholesterol absorption.
Colestyramine:
anion exchange resin. Binds to bile acids and stops them from being reabsorbed. Leads to increased conversion of newly synthesised cholesterol into bile acids and increased uptake of LDL by the liver.
Fibrates:
agonists at a nuclear hormone receptor called PPAR alpha and seem to alter transcription of some of the genes involved in lipid metabolism. Their overall effect though is to reduce plasma LDL. Also reduce fibrinogen. Mechanism not well known.
What is an Embolus?
blood clot that has become detached from the vessel wall and is travelling through the blood.
may lodge in a small vessel, block it and cut off the blood supply to tissue
Enoxoparin
low molecular weight heparin, does not bind to thrombin but does increase the affinity of antithrombin iii for factor Xa
Factor Xa
enzyme in clotting cascade
produced from inactive factor X by the actions of factor ixa, converts prothrombin–> thrombin.
target of heparin and low molecular weight heparin
Prostacyclin
aka prostaglandin 12
naturally occuring inhibitor of platelet aggregation
plays an important role in regulating coagulation
produced by epithelial cells lining inttact blood vessels
Streptokinase
clot busting drug- activator of plaminogen.
can restore blood supply if given in a short time after stroke or myocardial infarction
Reteplase
clot busting drug-activator of plaminogen.
can restore blood supply if given in a short time after stroke or myocardial infarction
Epoprostenol
synthetic version of prostacyclin
mimics the anticoagulant actions of prostacyclin
very short plasma half life
causes flushing, headache and hypotension
Clopidogrel
irreversible antagonist at ADP receptors
inhibitor of platelet aggregation
used to prevent thrombosis